Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
18,239,051
-
Shares change
-
+63,737
-
Total reported value, excl. options
-
$119,650,574
-
Value change
-
-$420,614
-
Put/Call ratio
-
257%
-
Number of buys
-
46
-
Number of sells
-
-41
-
Price
-
$6.56
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q1 2018
107 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q1 2018.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,239,051 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,151,578 shares), JPMORGAN CHASE & CO (2,863,044 shares), BlackRock Inc. (2,262,977 shares), FMR LLC (1,994,672 shares), VANGUARD GROUP INC (1,349,300 shares), STATE STREET CORP (450,332 shares), ASCEND CAPITAL, LLC (400,994 shares), MORGAN STANLEY (362,167 shares), Boxer Capital, LLC (350,000 shares), and NORTHERN TRUST CORP (313,198 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.